共 184 条
- [1] Asakura H(2014)Classifying types of disseminated intravascular coagulation: clinical and animal models J Intensive Care 2 20-e1143
- [2] Evans L(2021)Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 Crit Care Med 49 e1063-331
- [3] Rhodes A(2021)The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) J Intensive Care 9 53-394
- [4] Alhazzani W(2002)Antithrombin, heparin, and heparan sulfate Crit Care Med 30 S325-1383
- [5] Antonelli M(2002)High-dose antithrombin therapy for sepsis: mechanisms of action Shock 18 389-1625
- [6] Coopersmith CM(2020)Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis Int J Mol Sci 22 176-173
- [7] French C(2022)Impact of antithrombin activity levels following recombinant antithrombin gamma therapy in patients with sepsis-induced disseminated intravascular coagulation Clin Appl Thromb Hemost 28 10760296221135790-428
- [8] Machado FR(2004)Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation Arterioscler Thromb Vasc Biol 24 1374-740
- [9] McIntyre L(2019)Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential Crit Care 23 280-140
- [10] Ostermann M(2020)Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis J Thromb Haemost 18 1618-131